drugset / Trial / NCT00082589

The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure

NCT00082589

Phase 4 Completed 250 enrolled Viatris Inc.
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if eplerenone is effective in the treatment of mild to moderate heart failure

Timeline

Start
2004-04
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplerenone Unknown 50 mg